Agios Pharmaceuticals, Inc. (NasdaqGS: AGIO)
Health Care · Biotechnology · US
$30.98
-2.61% today · -25.0% 1Y
Agios Pharmaceuticals, Inc. (NasdaqGS: AGIO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.90B and employs 540 people.
Over the last twelve months the share price has lost 25.0%, trading between 22.24 and 46.00.
Tweenvest scores Agios Pharmaceuticals, Inc. across four factors: quality 38/100, value 69/100. Its strongest factor is value.
AGIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.90B
- Revenue (TTM)
- $98.34M
- P/E
- —
- EPS
- -7.01
- Dividend yield
- —
- Beta (5Y)
- 0.63
- 52-week high
- $46.00
- 52-week low
- $22.24
- Avg volume (3M)
- —
- Shares outstanding
- 59.70M
- Employees
- 540
- Next earnings
- —
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is developing AG-946, which is currently undergoing Phase I clinical studies for treating hemolytic anemias and other diseases. Established in 2007, the company's main office is located in Cambridge, Massachusetts.
- ISIN
- US00847X1046
- Founded
- 2007
- Listed since
- Jul 24, 2013
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vir Biotechnology, Inc.NasdaqGS: VIR | $1.98B | $11.30 | -3.42% |
| Jinyu Bio-technology Co., Ltd.SHSE: 600201 | $1.93B | CN¥11.84 | +1.98% |
| Pell Bio-Med Technology Co., Ltd.TWSE: 6949 | $1.92B | NT$46.85 | +5.28% |
| Lakefront Biotherapeutics NVENXTAM: LKFT | $1.92B | €26.32 | +1.70% |
| Sarepta Therapeutics, Inc.NasdaqGS: SRPT | $1.89B | $17.43 | -2.35% |
| Voronoi, Inc.KOSDAQ: A310210 | $1.87B | ₩138,400.00 | -3.96% |
| Intellia Therapeutics, Inc.NasdaqGM: NTLA | $1.83B | $12.65 | -3.21% |
| Xencor, Inc.NasdaqGM: XNCR | $1.83B | $24.88 | +1.02% |
Figures last refreshed Oct 11, 2026.